logo
Select company
Select metric
7.53Current Ratio
VS
Market
89
Sector
78
Industry
67
History
38
$ 18.81Close
$ 7.38 - $ 61.57 52-Week Range
Ticker Information

Ticker

TNXP

Company Name

TONIX PHARMACEUTICALS HOLDING CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TONIX PHARMACEUTICALS HOLDING CORP - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TNXP - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 143.53M7.53$ 19.06M
3/31/2025$ 149.57M12.31$ 12.15M
12/31/2024$ 119M6.5$ 18.31M
9/30/2024$ 50.54M3.33$ 15.18M
6/30/2024$ 25.29M1.15$ 22.04M
3/31/2024$ 30.1M1.47$ 20.48M
12/31/2023$ 47.77M2.53$ 18.88M
9/30/2023$ 31.34M1.77$ 17.73M
6/30/2023$ 51.33M2.78$ 18.44M
3/31/2023$ 83.73M6.4$ 13.07M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TONIX PHARMACEUTICALS HOLDING CORP's latest trailing twelve months (TTM) Current Ratio stands at 14.17.
  • Over the past 5 years, TONIX PHARMACEUTICALS HOLDING CORP's average Current Ratio has been 9.25.
  • The median Current Ratio for TONIX PHARMACEUTICALS HOLDING CORP during this period was 8.12
  • TONIX PHARMACEUTICALS HOLDING CORP reached its highest Current Ratio over the past 5 years at 28.73.
  • The lowest Current Ratio recorded by TONIX PHARMACEUTICALS HOLDING CORP in the same timeframe 1.15

TONIX PHARMACEUTICALS HOLDING CORP's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
PRTA : PROTHENA CORP PUBLIC LTD CO 5.68CAPR : CAPRICOR THERAPEUTICS INC 4.37LCTX : LINEAGE CELL THERAPEUTICS INC 4.08RLAY : RELAY THERAPEUTICS INC 20.92ABSI : ABSCI CORP 4.39PRME : PRIME MEDICINE INC 3.56TVRD : TVARDI THERAPEUTICS INC 4.04OCGN : OCUGEN INC 1.83FATE : FATE THERAPEUTICS INC 8.04SRZN : SURROZEN INC 16.41

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for TONIX PHARMACEUTICALS HOLDING CORP is calculated as follows: AssetsC [ $ 62.02M ] / LiabilitesC [ $ 4.38M ]
(=) Current Ratio [ 14.17 ]

TNXP - Current Ratio, Last 5 years

1.15

Minimum

Jun 30, 2024

28.73

Maximum

Mar 31, 2021

9.25

Average

8.12

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44